Letter from the Editor

Dear readers,

EULAR 2025 took place at the Fira de Barcelona from 11 to 14 June and was attended by over 14,000 delegates from around the world. Together with Prof. Luca Quartuccio (University of Udine, Italy) and our editorial team, we are pleased to present the highlights from the meeting, including novel data from inflammatory and degenerative rheumatic diseases that may help shape the future of clinical practice.

The report covers emerging therapies, novel insights into current treatments, and promising data focusing on strategies towards the interception and prevention of rheumatic diseases.

We hope you find this edition insightful, and we look forward

to seeing you in London for EULAR 2026.

 

Warm regards,

Prof. Dennis McGonagle

 

Biography

Dennis McGonagle, FRCPI, PhD, is an Academic Rheumatologist at the University of Leeds and section head of Experimental Rheumatology. He graduated in Medicine from the University College Dublin in 1990 and undertook postgraduate training in Dublin and Leeds where he completed his PhD. He has developed the modern enthesitis model for spondyloarthropathies and psoriatic arthritis including the cytokine-mediated

enthesis-originating theory of disease (Lancet 1998). He also described the synovioentheseal complex, nail anchorage to the skeleton, developed an integrated biomechanical and immunology model for PsA, and a mechanistic disease classification of immune diseases (PLoS Med 2006). His group also discovered synovial fluid mesenchymal stem cells, which is being researched towards osteoarthritis therapy development. Prof. McGonagle has also served on the EULAR scientific committee and is a member of the Editorial Board of ARD, and has won several international awards including the Carol Nachman Prize in 2023.

Conflict of Interest Statement: Prof. McGonagle has undertaken research and/or educational programme activities with Pfizer, MSD, AbbVie, BMS, UCB, Novartis, Lilly, Celgene, Moonlake, and J&J.



Posted on 8 August 20258 August 2025